Clinical Trials List
Protocol NumberLOXO-RET-17001（J2G-OX-JZJA）
Active
2018-04-30 - 2026-12-31
Phase I/II
Recruiting2
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- TSUNG -YING YANG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 林育麟 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 楊景堯 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 林宗哲 Division of Hematology & Oncology
- 許嘉林 Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
870 participants
